Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Editorial: Current opinion in organ transplantation: lung transplantation.

Glanville AR.

Curr Opin Organ Transplant. 2019 Jun;24(3):286-287. doi: 10.1097/MOT.0000000000000644. No abstract available.

PMID:
31090637
2.

Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT.

Glanville AR, Verleden GM, Todd JL, Benden C, Calabrese F, Gottlieb J, Hachem RR, Levine D, Meloni F, Palmer SM, Roman A, Sato M, Singer LG, Tokman S, Verleden SE, von der Thüsen J, Vos R, Snell G.

J Heart Lung Transplant. 2019 May;38(5):483-492. doi: 10.1016/j.healun.2019.03.008. Epub 2019 Apr 3. No abstract available.

PMID:
31027539
3.

Current opinion in organ transplantation: lung transplantation.

Glanville AR.

Curr Opin Organ Transplant. 2019 Apr 9. doi: 10.1097/MOT.0000000000000644. [Epub ahead of print] No abstract available.

PMID:
30973414
4.

Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT.

Verleden GM, Glanville AR, Lease ED, Fisher AJ, Calabrese F, Corris PA, Ensor CR, Gottlieb J, Hachem RR, Lama V, Martinu T, Neil DAH, Singer LG, Snell G, Vos R.

J Heart Lung Transplant. 2019 May;38(5):493-503. doi: 10.1016/j.healun.2019.03.009. Epub 2019 Apr 3. No abstract available.

PMID:
30962148
5.

Kinetics of TTV-DNA Plasma Load: A Global Measure of Immune Suppression?

Mitchell AB, Glanville AR.

Transplantation. 2019 Apr;103(4):660-661. doi: 10.1097/TP.0000000000002437. No abstract available.

PMID:
30907854
6.

Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.

De Rosa N, Paddon VL, Liu Z, Glanville AR, Parsi K.

JAMA Dermatol. 2019 Mar 13. doi: 10.1001/jamadermatol.2018.4789. [Epub ahead of print]

PMID:
30865218
7.

Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection.

Darley DR, Carlos L, Hennig S, Liu Z, Day R, Glanville AR.

Eur J Clin Pharmacol. 2019 Jul;75(7):879-888. doi: 10.1007/s00228-019-02658-5. Epub 2019 Mar 12.

PMID:
30859243
8.

Montelukast for chronic lung allograft dysfunction: Not quite the "Full Monty".

Glanville AR.

J Heart Lung Transplant. 2019 May;38(5):528-529. doi: 10.1016/j.healun.2019.01.1312. Epub 2019 Jan 30. No abstract available.

PMID:
30765304
9.

Controversies and emerging topics in lung transplantation.

Abelson D, Glanville AR.

Breathe (Sheff). 2018 Dec;14(4):278-287. doi: 10.1183/20734735.027018.

10.

Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimens.

Milliken E, de Zwart AES, Alffenaar JC, Marriott DJE, Riezebos-Brilman A, Schteinman A, Evans AM, Glanville AR, Verschuuren EAM, Reuter SE.

J Antimicrob Chemother. 2019 Mar 1;74(3):691-698. doi: 10.1093/jac/dky466.

PMID:
30452661
11.

Older Patients' Perspectives of Online Health Approaches in Chronic Obstructive Pulmonary Disease.

Disler RT, Inglis SC, Newton P, Currow DC, Macdonald PS, Glanville AR, Donesky D, Carrieri-Kohlman V, Davidson PM.

Telemed J E Health. 2018 Nov 5. doi: 10.1089/tmj.2018.0098. [Epub ahead of print]

PMID:
30394859
12.

Coronavirus and Chronic Lung Allograft Dysfunction: Hiding in Plain Sight?

Mitchell AB, Glanville AR.

Transplant Direct. 2018 Jul 11;4(8):e371. doi: 10.1097/TXD.0000000000000809. eCollection 2018 Aug. No abstract available.

13.

Transplanting the pulmonary virome: Dynamics of transient populations.

Mitchell AB, Mourad B, Morgan LC, Oliver BGG, Glanville AR.

J Heart Lung Transplant. 2018 Sep;37(9):1111-1118. doi: 10.1016/j.healun.2018.06.002. Epub 2018 Jun 9.

PMID:
30173825
14.

Introduction to Techniques and Methodologies for Characterizing the Human Respiratory Virome.

Mitchell AB, Glanville AR.

Methods Mol Biol. 2018;1838:111-123. doi: 10.1007/978-1-4939-8682-8_9. Review.

PMID:
30128993
15.

Lung transplantation for non-small cell lung cancer and multifocal bronchioalveolar cell carcinoma.

Glanville AR, Wilson BE.

Lancet Oncol. 2018 Jul;19(7):e351-e358. doi: 10.1016/S1470-2045(18)30297-3. Epub 2018 Jun 29. Review.

PMID:
30084382
16.

High prevalence of diabetes before and after lung transplantation: target for improving outcome?

Fazekas-Lavu M, Reyes M, Malouf M, Plit M, Havryk A, Campbell LV, Center JR, Glanville AR, Greenfield JR.

Intern Med J. 2018 Aug;48(8):916-924. doi: 10.1111/imj.13963.

PMID:
29740976
17.

Advances in ex-vivo donor lung organ care.

Glanville AR.

Lancet Respir Med. 2018 May;6(5):319-320. doi: 10.1016/S2213-2600(18)30144-9. Epub 2018 Apr 9. No abstract available.

PMID:
29650409
18.

The Human Respiratory Microbiome: Implications and Impact.

Mitchell AB, Glanville AR.

Semin Respir Crit Care Med. 2018 Apr;39(2):199-212. doi: 10.1055/s-0037-1617441. Epub 2018 Mar 26. Review.

PMID:
29579771
19.

Lung Transplantation: Controversies and Evolving Concepts.

Belperio JA, Glanville AR.

Semin Respir Crit Care Med. 2018 Apr;39(2):115-116. doi: 10.1055/s-0037-1617413. Epub 2018 Mar 26. No abstract available.

PMID:
29579764
20.

Systematic review and meta-analysis of post-transplant lymphoproliferative disorder in lung transplant recipients.

Cheng J, Moore CA, Iasella CJ, Glanville AR, Morrell MR, Smith RB, McDyer JF, Ensor CR.

Clin Transplant. 2018 May;32(5):e13235. doi: 10.1111/ctr.13235. Epub 2018 Mar 30.

21.

Acute rejection.

Benzimra M, Calligaro GL, Glanville AR.

J Thorac Dis. 2017 Dec;9(12):5440-5457. doi: 10.21037/jtd.2017.11.83. Review. Erratum in: J Thorac Dis. 2018 Feb;10 (2):E165.

22.

The distal airway microbiome after lung transplantation: A driver of immune regulation?

Mitchell AB, Glanville AR.

J Heart Lung Transplant. 2017 Nov 22. pii: S1053-2498(17)32118-6. doi: 10.1016/j.healun.2017.11.017. [Epub ahead of print] No abstract available.

PMID:
29221917
23.

Lung autoantibodies: Ready for prime time?

Milross L, Hachem R, Levine D, Glanville AR.

J Heart Lung Transplant. 2017 Nov 8. pii: S1053-2498(17)32095-8. doi: 10.1016/j.healun.2017.10.026. [Epub ahead of print]

PMID:
29198928
24.

Chest pain and recurrent chylothorax: an unusual presentation of malignant pleural mesothelioma.

Darley DR, Granger E, Glanville AR.

Respirol Case Rep. 2017 Jun 15;5(5):e00250. doi: 10.1002/rcr2.250. eCollection 2017 Sep.

25.

Herpes simplex virus-2 transmission following solid organ transplantation: Donor-derived infection and transplantation from prior organ recipients.

Macesic N, Abbott IJ, Kaye M, Druce J, Glanville AR, Gow PJ, Hughes PD, Korman TM, Mulley WR, O'Connell PJ, Opdam H, Paraskeva M, Pitman MC, Setyapranata S, Rawlinson WD, Johnson PDR.

Transpl Infect Dis. 2017 Oct;19(5). doi: 10.1111/tid.12739. Epub 2017 Jul 31.

PMID:
28618165
26.

Physiology of chronic lung allograft dysfunction: back to the future?

Glanville AR.

Eur Respir J. 2017 Apr 12;49(4). pii: 1700187. doi: 10.1183/13993003.00187-2017. Print 2017 Apr. No abstract available.

27.

Translational Aspects of the Human Respiratory Virome.

Mitchell AB, Oliver BG, Glanville AR.

Am J Respir Crit Care Med. 2016 Dec 15;194(12):1458-1464. Review.

PMID:
27653942
28.

Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection.

Jensen TO, Darley DR, Goeman EE, Shaw K, Marriott DJ, Glanville AR.

Transpl Infect Dis. 2016 Oct;18(5):782-784. doi: 10.1111/tid.12580. Epub 2016 Sep 7.

PMID:
27459235
29.

Liver and lung transplantation in cystic fibrosis: an adult cystic fibrosis centre's experience.

Sivam S, Al-Hindawi Y, Di Michiel J, Moriarty C, Spratt P, Jansz P, Malouf M, Plit M, Pleass H, Havryk A, Bowen D, Haber P, Glanville AR, Bye PT.

Intern Med J. 2016 Jul;46(7):852-4. doi: 10.1111/imj.13126.

PMID:
27405894
30.

Age-related survival disparity associated with lung transplantation in cystic fibrosis: An analysis of the registry of the International Society for Heart and Lung Transplantation.

Hayes D Jr, Glanville AR, McGiffin D, Tobias JD, Tumin D.

J Heart Lung Transplant. 2016 Sep;35(9):1108-15. doi: 10.1016/j.healun.2016.04.015. Epub 2016 May 6.

PMID:
27296835
31.

Don't Let (Dl)CO Be Misunderstood.

Glanville AR, Hoeper MM.

Am J Respir Crit Care Med. 2016 Jun 1;193(11):1200-1. doi: 10.1164/rccm.201601-0079ED. No abstract available.

PMID:
27248589
32.

Novel autologous T-cell therapy for drug-resistant cytomegalovirus disease after lung transplantation.

Pierucci P, Malouf M, Glanville AR, Beagley L, Smith C, Khanna R.

J Heart Lung Transplant. 2016 May;35(5):685-7. doi: 10.1016/j.healun.2015.12.031. Epub 2016 Jan 7. No abstract available.

PMID:
27083238
33.

Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation.

Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ, Hachem R, Hayes D Jr, Neil D, Reinsmoen NL, Snyder LD, Sweet S, Tyan D, Verleden G, Westall G, Yusen RD, Zamora M, Zeevi A.

J Heart Lung Transplant. 2016 Apr;35(4):397-406. doi: 10.1016/j.healun.2016.01.1223. Epub 2016 Feb 10. Review.

PMID:
27044531
34.

Patient-reported symptoms and functioning as indicators of mortality in advanced cystic fibrosis: A new tool for referral and selection for lung transplantation.

Solé A, Pérez I, Vázquez I, Pastor A, Escrivá J, Sales G, Hervás D, Glanville AR, Quittner AL.

J Heart Lung Transplant. 2016 Jun;35(6):789-94. doi: 10.1016/j.healun.2016.01.1233. Epub 2016 Feb 12.

PMID:
27021279
35.

Lung transplantation using controlled donation after circulatory death donors: Trials and tribulations.

Cypel M, Levvey B, Van Raemdonck D, Erasmus M, Dark J, Mason D, Glanville AR, Chambers D, Edwards L, Stehlik J, Hertz M, Whitson BA, Yusen RD, Hopkins P, Snell G, Keshavjee S.

J Heart Lung Transplant. 2016 Jan;35(1):146-7. doi: 10.1016/j.healun.2015.10.004. Epub 2015 Nov 6. Review. No abstract available.

PMID:
26552615
36.

A rare case of everolimus-induced pulmonary alveolar proteinosis.

Darley DR, Malouf MA, Glanville AR.

J Heart Lung Transplant. 2016 Jan;35(1):147-8. doi: 10.1016/j.healun.2015.10.001. Epub 2015 Oct 9. No abstract available.

PMID:
26525403
37.

International Society for Heart and Lung Transplantation Donation After Circulatory Death Registry Report.

Cypel M, Levvey B, Van Raemdonck D, Erasmus M, Dark J, Love R, Mason D, Glanville AR, Chambers D, Edwards LB, Stehlik J, Hertz M, Whitson BA, Yusen RD, Puri V, Hopkins P, Snell G, Keshavjee S; International Society for Heart and Lung Transplantation.

J Heart Lung Transplant. 2015 Oct;34(10):1278-82. doi: 10.1016/j.healun.2015.08.015. Epub 2015 Sep 3.

PMID:
26454741
38.

ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients.

Gottlieb J, Zamora MR, Hodges T, Musk AW, Sommerwerk U, Dilling D, Arcasoy S, DeVincenzo J, Karsten V, Shah S, Bettencourt BR, Cehelsky J, Nochur S, Gollob J, Vaishnaw A, Simon AR, Glanville AR.

J Heart Lung Transplant. 2016 Feb;35(2):213-21. doi: 10.1016/j.healun.2015.08.012. Epub 2015 Sep 3.

PMID:
26452996
39.

Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.

Kumarasinghe G, Lavee O, Parker A, Nivison-Smith I, Milliken S, Dodds A, Joseph J, Fay K, Ma DD, Malouf M, Plit M, Havryk A, Keogh AM, Hayward CS, Kotlyar E, Jabbour A, Glanville AR, Macdonald PS, Moore JJ.

J Heart Lung Transplant. 2015 Nov;34(11):1406-14. doi: 10.1016/j.healun.2015.05.021. Epub 2015 Jun 11.

PMID:
26279197
40.

Bacteremic Inquilinus limosus empyema in an Australian lung transplant patient with cystic fibrosis.

Goeman E, Shivam A, Downton TD, Glanville AR.

J Heart Lung Transplant. 2015 Sep;34(9):1220-3. doi: 10.1016/j.healun.2015.06.013. Epub 2015 Jul 4. No abstract available.

PMID:
26267744
41.

Patterns of technology use in patients attending a cardiopulmonary outpatient clinic: a self-report survey.

Disler RT, Inglis SC, Newton PJ, Currow DC, Macdonald PS, Glanville AR, Donesky D, Carrieri-Kohlman V, Davidson PM.

Interact J Med Res. 2015 Mar 6;4(1):e5. doi: 10.2196/ijmr.3955.

42.

Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency.

Burrows FS, Carlos LM, Benzimra M, Marriott DJ, Havryk AP, Plit ML, Malouf MA, Glanville AR.

J Heart Lung Transplant. 2015 Jul;34(7):958-62. doi: 10.1016/j.healun.2015.01.009. Epub 2015 Jan 16.

PMID:
25753833
43.

Regional differences in ventilation-perfusion ratio may help explain the differential diagnosis in interstitial lung disease.

Wang LW, Kwan BC, Glanville AR.

Intern Med J. 2015 Mar;45(3):365-7. doi: 10.1111/imj.12694. No abstract available.

PMID:
25735587
44.

An international ISHLT/ATS/ERS clinical practice guideline: summary for clinicians. Bronchiolitis obliterans syndrome complicating lung transplantation.

Welsh CH, Wang TS, Lyu DM, Orr J, Meyer KC, Glanville AR, Verleden GM, Wilson KC, Thomson CC, The American Thoracic Society Implementation Task Force.

Ann Am Thorac Soc. 2015 Jan;12(1):118-9. doi: 10.1513/AnnalsATS.201410-471CME. Review. No abstract available.

PMID:
25635657
45.

Pulmonary tumor thrombotic microangiopathy from metastatic prostate carcinoma.

Nayyar D, Muthiah K, Hayward CS, Lim Z, Granger EK, Nicholls M, Glanville AR.

Case Rep Pulmonol. 2015;2015:286962. doi: 10.1155/2015/286962. Epub 2015 Jan 6.

46.

Tacrolimus rescue therapy for severe respiratory failure in the anti-synthetase syndrome.

Rigby AL, Plit M, Glanville AR.

Respirol Case Rep. 2014 Jun;2(2):70-2. doi: 10.1002/rcr2.52. Epub 2014 Feb 25.

47.

CLAD: does the Emperor have new clothes?

Glanville AR.

Am J Transplant. 2014 Dec;14(12):2681-2. doi: 10.1111/ajt.12943. Epub 2014 Nov 13. No abstract available.

48.

An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome.

Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC, Brozek J, Glanville AR; ISHLT/ATS/ERS BOS Task Force Committee; ISHLT/ATS/ERS BOS Task Force Committee.

Eur Respir J. 2014 Dec;44(6):1479-503. doi: 10.1183/09031936.00107514. Epub 2014 Oct 30.

49.

Should mammalian target of rapamycin inhibitors be stopped in women with lymphangioleiomyomatosis awaiting lung transplantation?

El-Chemaly S, Goldberg HJ, Glanville AR.

Expert Rev Respir Med. 2014 Dec;8(6):657-60. doi: 10.1586/17476348.2014.956728. Epub 2014 Sep 9.

PMID:
25199529
50.

A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation.

Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S, Lederer DJ, Mulligan MJ, Patterson GA, Singer LG, Snell GI, Verleden GM, Zamora MR, Glanville AR.

J Heart Lung Transplant. 2015 Jan;34(1):1-15. doi: 10.1016/j.healun.2014.06.014. Epub 2014 Jun 26. Review.

PMID:
25085497

Supplemental Content

Loading ...
Support Center